FDA Committee Recommends Hospira’s Epogen/Procrit Biosimilar for Approval

Generic Line
A A
An FDA advisory committee endorsed Hospira’s biosimilar version of Epogen and Procrit, used to stimulate the production of red blood cells.

To View This Article:

Login

Subscribe To Generic Line

Buy This Article Now

Add this article to your cart for $40.00